Skip to Main Content

Paper Details

Prostate-specific antigen response and clinical progression-free survival in Black and White men with chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide in a real-world setting.
Prostate Cancer Prostatic Dis
2
2023
Author NameAffiliation
Stephen J FreedlandCenter for Integrated Research in Cancer and Lifestyle, Cedars-Sinai Medical Center
Stephen J Freedland
  • 1 - 2

Datasets

Release 1.2